ALL

Clinical trials for ALL explained in plain language.

Never miss a new study

Get alerted when new ALL trials appear

Sign up with your email to follow new studies for ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet recruiting 1 Not yet finished but already full! 2 Completed 2 Terminated 1

Promising combo study halted early: only 4 patients enrolled

Disease control Terminated

This study tested whether adding the drug rapamycin to high-dose chemotherapy could help people with aggressive blood cancers that had come back or not responded to treatment. The trial was open to adults aged 18 to 65 with certain types of leukemia or lymphoma. Only 4 people too…

Matched conditions: ALL

Phase: PHASE1, PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control

Last updated May 17, 2026 06:48 UTC

ALL

Get alerted when new ALL trials appear

Promising combo study halted early: only 4 patients enrolled